TY - JOUR
T1 - Extracellular Vesicles as Therapeutics for Brain Injury and Disease
AU - Upadhya, Dinesh
AU - Shetty, Ashok K.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Extracellular vesicles (EVs) are gaining tremendous importance in comprehending central nervous system (CNS) function and treating neurological disorders because of their role in intercellular communication and reparative processes, and suitability as drug delivery vehicles. Since EVs have lipid membranes, they cross the blood-brain barrier easily and communicate with target neurons and glia even deep inside the brain. EVs from various sources have been isolated, characterized, and tailored for promoting beneficial effects in conditions, such as brain injury and disease. Particularly, EVs isolated from mesenchymal stem cells and neural stem cells have shown promise for alleviating brain dysfunction after injury or disease. Such properties of stem cell-derived EVs have great importance for clinical applications, as EV therapy can avoid several concerns typically associated with cell therapy. This minireview confers the competence of EVs for improving brain function by modulating CNS injury and disease.
AB - Extracellular vesicles (EVs) are gaining tremendous importance in comprehending central nervous system (CNS) function and treating neurological disorders because of their role in intercellular communication and reparative processes, and suitability as drug delivery vehicles. Since EVs have lipid membranes, they cross the blood-brain barrier easily and communicate with target neurons and glia even deep inside the brain. EVs from various sources have been isolated, characterized, and tailored for promoting beneficial effects in conditions, such as brain injury and disease. Particularly, EVs isolated from mesenchymal stem cells and neural stem cells have shown promise for alleviating brain dysfunction after injury or disease. Such properties of stem cell-derived EVs have great importance for clinical applications, as EV therapy can avoid several concerns typically associated with cell therapy. This minireview confers the competence of EVs for improving brain function by modulating CNS injury and disease.
UR - http://www.scopus.com/inward/record.url?scp=85075813709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075813709&partnerID=8YFLogxK
U2 - 10.2174/1381612825666191014164950
DO - 10.2174/1381612825666191014164950
M3 - Article
C2 - 31612823
SN - 1381-6128
VL - 25
SP - 3500
EP - 3505
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 33
ER -